DuPont Announces Agreement to Divest Aramids Business to Arclin

Core Viewpoint - DuPont has announced a definitive agreement for Arclin to acquire its Aramids business, which includes Kevlar® and Nomex®, in a transaction valued at approximately $1.8 billion [1][3][4]. Transaction Details - The transaction is expected to close in the first quarter of 2026, pending customary closing conditions and regulatory approval [2]. - Upon closing, DuPont will receive pre-tax cash proceeds of approximately $1.2 billion, a note receivable of $300 million, and a non-controlling common equity interest in Arclin valued at $325 million, representing an estimated 17.5% stake [3]. Strategic Implications - The divestiture is part of DuPont's strategy to optimize its portfolio, enhancing its focus and improving growth and margin profiles [4][7]. - DuPont aims to redeploy the significant cash proceeds from the transaction to drive further value creation for shareholders [4]. Arclin's Perspective - Arclin's acquisition of the Aramids business is expected to enhance its scale, global reach, and application development capabilities, allowing for impactful solutions and products [6]. - The Aramids business generated net sales of $1.3 billion in 2024 and is recognized as the largest global producer of high-performance synthetic fibers [6]. Financial Advisors - Centerview Partners and Goldman Sachs & Co. LLC are serving as financial advisors to DuPont, while Piper Sandler & Company is advising TJC/Arclin [7].